'Mixed‑case lettering’: Principles for application
This fact sheet has been developed to assist health service organisations (HSOs) and clinicians involved in medication management; for instance, those involved in the prescribing, dispensing and administration of medicines. It can be used to assist in the understanding of the application of ‘mixed-case’ lettering as a risk-reduction strategy.
The fact sheet includes some principles for the application of ‘mixed-case’ lettering and provides guidance on the risk assessment process and how to apply ‘mixed-case’ lettering to locally identified LASA medicine names.
Downloads
'Mixed‑case lettering’: Principles for application
- Publication Year:
- 2024
- Resource Type:
- Fact sheet
Accessibility: We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
Copyright: Unless stated otherwise, materials provided are covered by a Creative Commons Attribution-Non-Commercial-No Derivatives (BY-NC-ND) 4.0 International License.
Request permission to reproduce material produced by the Commission by emailing our Communications team.